Last reviewed · How we verify

NCT02953977: SMSC

Strong Men, Strong Communities Diabetes Risk Reduction in American Indian Men

Completed NA Last updated 14 August 2023
What this trial tests

NA trial testing Diabetes Prevention Program in Diabetes in 257 participants. Completed in 30 June 2023.

Timeline
15 June 2018
Primary endpoint
30 October 2021
30 June 2023

Quick facts

Lead sponsorWashington State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment257
Start date15 June 2018
Primary completion30 October 2021
Estimated completion30 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington State University

Who can join

Adults 18 to 75, male only, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SMSC will inform the design and implementation of culturally informed, community-based lifestyle interventions for diabetes prevention in AI men in our partner communities and elsewhere, as well as in men of other minority groups who experience a heavy burden of diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diabetes Prevention Program

Trials testing the same drug.

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other Washington State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02953977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing